Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- University of Washington
- University of Pennsylvania
- University of North Carolina at Chapel Hill
- Rutgers University
- University of California
- Duke University
- The Ohio State University
- The University of Chicago
- University of Florida
- University of Michigan - Ann Arbor
- University of Utah
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- University of Minnesota
- Dana-Farber Cancer Institute
- IBIMA Plataforma BIONAND
- University of Glasgow
- Cedars-Sinai Medical Center
- Fred Hutchinson Cancer Center
- George Mason University
- INSERM
- Indiana University
- University of California, Los Angeles
- University of Colorado
- University of Gdansk
- CNRS
- CRUK Manchester Institute
- Fundación Investigación del Cáncer Universidad de Salamanca
- Georgetown University
- Harvard University
- Lunds universitet
- Medical University of Gdańsk
- SUNY University at Buffalo
- Stanford University
- The University of Arizona
- The University of Iowa
- University of Birmingham
- University of Cambridge;
- University of Kentucky
- University of Maryland, Baltimore
- University of Sheffield
- Yale University
- ADELAIDE UNIVERSITY
- Akademia Wychowania Fizycznego Józefa Piłsudskiego w Warszawie
- Autonomous University of Madrid (Universidad Autónoma de Madrid)
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Dana-Farber Cancer Institute (DFCI)
- Helmholtz Association of German Research Centres
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- Institut Pasteur
- Institute of Bioorganic Chemistry Polish Academy of Sciences
- Institute of Macromolecular Chemistry CAS
- Institute of Physical Chemistry, Polish Academy of Sciences
- Itä-Suomen yliopisto
- Josep Carreras Leukaemia Research Institute (IJC)
- Luxembourg Institute of Health
- MASARYK UNIVERSITY
- Masaryk University – Faculty of Medicine
- Memorial Sloan-Kettering Cancer Center
- Michigan State University
- Nencki Institute of Experimental Biology
- Purdue University
- Radboud University Medical Center (Radboudumc)
- Research Center for Molecular Medicine (CeMM), ÖAW
- SciLifeLab
- St Jude Children's Research Hospital
- The University of North Carolina at Chapel Hill
- UCL;
- Umeå University
- University Hospital Magdeburg
- University of Alabama at Birmingham
- University of Aveiro
- University of Birmingham;
- University of California Irvine
- University of California, San Diego
- University of Chicago (UC)
- University of Kansas Medical Center
- University of Mainz
- University of Maryland School of Medicine, Baltimore
- University of Nevada, Reno
- University of Newcastle
- University of Pittsburgh, Pittsburgh , Pennsylvania, US
- University of South Carolina
- University of Texas at Austin
- University of Tübingen − Faculty of Medicine
- Università Campus Bio-Medico di Roma
- Università degli studi "G. D'Annunzio CH-PE
- Université Paris Cité
- Utrecht University
- Virginia Tech
- Washington University in St. Louis
- 80 more »
- « less
-
Field
-
) at Uppsala University and SciLifeLab , the national infrastructure for life science. Project description Immunotherapy has become a life-saving option for advanced cancer patients. However, only a minority of
-
research in the area of tumor immunology and cancer immunotherapy with a focus on the discovery and development of T cell therapy for cancer, including cell culture, immunologic assays, molecular assays
-
biological efficacy of antibody-drug-conjugates or antibody-polymer-drug-conjugates in the treatment of cancer (immunotherapy) using the following experimental methods: Determination of cell viability using
-
University of California, Los Angeles | Los Angeles, California | United States | about 2 months ago
focuses on developing innovative technologies to enable in vivo cell engineering (e.g., in vivo CAR T cells) for immunotherapies against cancer, autoimmune disorders, and infectious diseases. The successful
-
suppression and immunotherapy resistance in hepatocellular carcinoma (HCC), the third leading cause of cancer-related death worldwide. This Cancer Research UK Career Establishment Award funded project will use
-
to develop new future types of immunotherapies. Our main area of interest is the regulation of immune response loci, such as interferon-stimulated genes (ISGs). In our research, we use techniques of chromatin
-
Microbe 19:775-87). We are also developing nanotechnology-based immunotherapy for eliciting antiviral and antitumor immunity against human cancers induced by tumor viruses (Proc Natl Acad Sci U S A
-
have identified its expression also in immuno-suppressive macrophages. Inhibition of ALK1 improves the efficacy of immunotherapy as a result of profound alterations in the immune cell landscape. Here, we
-
, and cellular immunotherapy. Our Hematologic Malignancy/BMT/Cell Therapy group is a charter Core Center of the Blood and Marrow Transplant Clinical Trials Network for 20 years, has been FACT-accredited
-
Abramson Cancer Center seek a highly organized and proactive Research Administrative Coordinator to support a dynamic translational research environment in cancer immunotherapy. This position provides